Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.00 (0.12%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

RedHill Biopharma (US: RDHL)

Last close As at 21/11/2024

9.14

— 0.00 (0.00%)

Market capitalisation

323m

Edison Investment Research is terminating coverage on RedHill Biopharma. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | QuickView

Redhill Biopharma — Rapid COVID-19 Ph II/III programme progress

Healthcare | Update

Redhill Biopharma — First quarter with significant sales; Cosmo deal

Healthcare | Update

Redhill Biopharma — Rapid progress with COVID-19 programme

Healthcare | Update

Redhill Biopharma — Movantik acquisition completed; sales booked
Visit Website

Sector

Healthcare

Financials

Edison Investment Research is terminating coverage on RedHill Biopharma. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.